BeStock  
Stocks › Biotechnology › MNPR

Monopar Therapeutics MNPR

US equityMarket cap rank #3617Biotechnology
$69.00 −$1.29 (-1.84%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $67.35 -2.40%
Open$68.50
Prev close$70.29
Day range$67.36 – $69.86
Volume132.6K
Market cap$467.60M
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts6
Average target$128.67+86.5% vs. price
  • Buy 100%
Low $119.00Now $69.00Avg $128.67High $145.00

Recent rating changes

The last 20 actions on file set price targets from $115.00 to $145.00, averaging $125.90.

DateFirmRatingTarget
13 Nov 2026 JonesTrading BUY $130.00
13 Nov 2026 H.C. Wainwright BUY $125.00
13 Nov 2026 Barclays BUY $145.00
12 Nov 2026 Cantor Fitzgerald BUY $119.00
12 Nov 2026 H.C. Wainwright BUY $125.00
28 Sep 2026 Piper Sandler BUY $123.00
21 Sep 2026 H.C. Wainwright BUY $125.00
11 Sep 2026 Barclays BUY $145.00
17 Aug 2026 Morgan Stanley BUY $130.00
13 Aug 2026 H.C. Wainwright BUY $125.00
13 Aug 2026 Barclays BUY $128.00
12 Aug 2026 Cantor Fitzgerald HOLD $119.00
12 Aug 2026 JonesTrading BUY $130.00
12 Aug 2026 BTIG BUY $133.00
23 Jul 2026 Barclays BUY $125.00
22 Jul 2026 BTIG BUY $117.00
22 Jul 2026 Morgan Stanley BUY $115.00
22 Jul 2026 H.C. Wainwright BUY $125.00
1 Jul 2026 BTIG BUY $117.00
30 Jun 2026 BTIG BUY $117.00

Discussion

No comments yet — be the first to weigh in on MNPR.

Sign in to join the discussion.

Scroll to Top